SEPN Septerna, Inc.
$45.23▲ +2.21%
Healthcare
Other
After hours
$46.13▲ +1.99%
Oct 29, 4:54 PM ET
Volume 200.6K
Avg Volume (10D) 299.3K
Key Metrics & Fundamentals
Market Cap
$2.11B
P/E Ratio
–
Div Yield
0.00%
52W Range
17.55 - 51.10
% vs 50 MA
16.30%
% vs 200 MA
41.37%
RSI-14
71.5
MACD Histogram
+0.8700
Beta (1Y vs SPY)
0.98
Free Cash Flow
-$22.18M
Gross Rev
$26.75M
Gross Profit
$26.75M
EBITDA
-$16.41M
COGS
–
Operating Exp
$43.58M
Operating Income
-$16.84M
EBIT
-$16.84M
Pretax Income
-$12.06M
Net Income
-$13.03M
EPS (Diluted)
-0.29
Price & Volume History
Loading chart…
Recent News
Is Septerna (SEPN) Stock Too Rich, Or Still Reasonable?
Simply Wall St. · Oct 28, 2026 4:07 PM ET
Septerna (SEPN) Heads To Healthcare Conferences, Is The Valuation Already Too Rich?
Simply Wall St. · Sep 14, 2026 10:10 AM ET
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 10, 2026 4:00 PM ET
Septerna to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 8:00 AM ET
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
GlobeNewswire · Aug 25, 2026 8:00 AM ET
Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 10, 2026 5:10 PM ET
Septerna Q2 Loss Narrows, Revenue Rises
MT Newswires · Aug 10, 2026 4:26 PM ET
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 10, 2026 4:01 PM ET
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 5, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SEPN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.